Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PLKS as modifiers of the beta catenin pathway and methods of use

PLKS as modifiers of the beta catenin pathway and methods of use

US Patent 8632962 · Granted Jan 21, 2014

Estimated economic value: $12,108,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TGF-beta antibodies and their use2024
Anti-TGF-beta antibodies and their use2022
Anti-TGF-β antibodies and their use2020
Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer2019
Heterocyclic modulators of lipid synthesis and combinations thereof2019
Heterocyclic modulators of lipid synthesis2019
Heterocyclic modulators of lipid synthesis for use against cancer and viral infe2018
Methods for diagnosis, prognosis and methods of treatment2015
Methods for the identification and treatment of patients sensitive to anti IGF-12015
Compositions and methods for treating cancer2014
SCDs as modifiers of the p53 pathway and methods of use2014
SCDs as modifiers of the p53 pathway and methods of use2014